|Chemical and physical data|
|Molar mass||393.89 g·mol−1|
|3D model (JSmol)|
5F-JWH-398 (4'-chloro-AM-2201, Cl-2201, CLAM, SGT-20) is a recreational designer drug which is classed as a synthetic cannabinoid. It is from the naphthoylindole family, and produces cannabis-like effects. It was legally sold in New Zealand from 2012-2014 under the psychoactive substances scheme but was discontinued in May 2014 following the end of the interim approval period under the Psychoactive Substances Act 2013. Subsequently it has appeared on the illicit market around the world and was identified in Germany in May 2019.
- Davison I (27 April 2014). "Government to ban all legal highs within two weeks". Retrieved 30 November 2017 – via www.nzherald.co.nz.
- Rychert M, Wilkins C (November 2016). "Legal high industry business and lobbying strategies under a legal market for new psychoactive substances (NPS, 'legal highs') in New Zealand". The International Journal on Drug Policy. 37: 90–97. doi:10.1016/j.drugpo.2016.08.011. PMID 27639994.
- Rychert M, Wilkins C, Witten K (September 2017). "Issues with monitoring the safety of psychoactive products under a legal regulated market for new psychoactive substances ('legal highs') in New Zealand". Drug and Alcohol Review. 36 (5): 589–596. doi:10.1111/dar.12507. PMID 28229493. S2CID 20279160.
- European Monitoring Center for Drugs and Drug Addiction (December 2020). New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. An update from the EU Early Warning System (PDF). Luxembourg: Publications Office of the European Union. doi:10.2810/921262. ISBN 978-92-9497-558-4.